These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 28479357)
1. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study. Gabr MM; Mortada SM; Sallam MA J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357 [TBL] [Abstract][Full Text] [Related]
2. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability. Gabr MM; Mortada SM; Sallam MA Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488 [TBL] [Abstract][Full Text] [Related]
3. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. Rizwanullah M; Amin S; Ahmad J J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665 [TBL] [Abstract][Full Text] [Related]
4. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies. Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729 [TBL] [Abstract][Full Text] [Related]
5. Preparation and optimization of tablets containing a self-nano-emulsifying drug delivery system loaded with rosuvastatin. Salem HF; Kharshoum RM; Halawa AKA; Naguib DM J Liposome Res; 2018 Jun; 28(2):149-160. PubMed ID: 28287014 [TBL] [Abstract][Full Text] [Related]
6. Enhancing Solubility and Bioavailability of Rosuvastatin into Self Nanoemulsifying Drug Delivery System. Karasulu HY; Gundogdu E; Turk UO; Turgay T; Apaydin S; Simsir IY; Yilmaz C; Karasulu E Curr Drug Deliv; 2018; 15(7):1072-1082. PubMed ID: 29484996 [TBL] [Abstract][Full Text] [Related]
7. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Elgindy NA; Mehanna MM; Mohyeldin SM Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671 [TBL] [Abstract][Full Text] [Related]
8. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472 [TBL] [Abstract][Full Text] [Related]
9. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation. Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361 [TBL] [Abstract][Full Text] [Related]
10. Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation. Badie H; Abbas H Drug Dev Ind Pharm; 2018 Dec; 44(12):2013-2025. PubMed ID: 30095009 [TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated solid lipid nanoparticles. Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Erol K; Demirel M Int J Pharm; 2020 Mar; 578():119106. PubMed ID: 32014599 [TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Fathi HA; Allam A; Elsabahy M; Fetih G; El-Badry M Colloids Surf B Biointerfaces; 2018 Feb; 162():236-245. PubMed ID: 29197789 [TBL] [Abstract][Full Text] [Related]
13. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers. Rossetti FC; Depieri LV; Praça FG; Del Ciampo JO; Fantini MC; Pierre MB; Tedesco AC; Bentley MV Eur J Pharm Sci; 2016 Feb; 83():99-108. PubMed ID: 26657201 [TBL] [Abstract][Full Text] [Related]
15. Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: Physicochemical characterization and in vivo evaluation. Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Lee BJ; Park YJ; Yong CS; Kim JO; Choi HG Colloids Surf B Biointerfaces; 2017 Feb; 150():216-222. PubMed ID: 27918966 [TBL] [Abstract][Full Text] [Related]
16. Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery. Suares D; Prabhakar B Drug Dev Ind Pharm; 2017 Feb; 43(2):213-224. PubMed ID: 27593545 [TBL] [Abstract][Full Text] [Related]
17. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of lipid levels in triton induced hyperlipidemia rats through rosuvastatin calcium nanoparticles: Pharmacokinetic and pharmacodynamic studies. Dudhipala NR; Ettireddy SR; Puchakayala GR Chem Phys Lipids; 2021 Jul; 237():105081. PubMed ID: 33811848 [TBL] [Abstract][Full Text] [Related]
19. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol. Patil SS; Roy K; Choudhary B; Mahadik KR Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System. Nekkanti V; Wang Z; Betageri GV AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]